glp-1 drugs lawsuit Medications Ozempic Lawsuit: Are You Owed
Description
Exec SummaryDanuglipron is an experimental weight loss medication being developed by Pfizer
A new blockbuster class of therapeutics, glucagon-like peptide 1 (GLP-1) analogs (eg, semaglutide), shows promise at curbing both diseases
Experts warn that misuse of Ozempic and Mounjaro could trigger serious health risks without medical supervision.
#thirdcause
